Clinical Trial Update: Fasting Mimicking Diet Program to ImpRovE ChemoTherapy in Hormone Receptor Postive (HR+), HER2- Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a fasting mimicking diet program to improve chemotherapy outcomes in hormone receptor-positive, HER2-negative breast cancer; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Leiden University Medical Center | Conditions: Fasting Mimicking Diet, HER2-negative Breast Cancer | Phase 3 | Status: SUSPENDED